Anixa Biosciences, Inc. (NASDAQ: ANIX) CEO Dr Amit Kumar spoke with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The biotechnology company is focused on harnessing the body's immune system to fight cancer. It recently announced the commercial launch of its Cchek prostate cancer confirmation test.
Anixa Biosciences commercializing its Ccheck prostate cancer test, working on breast cancer vaccine
Quick facts: Anixa Biosciences
Price: 1.68 USD
Market Cap: $35.29 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE